The US FDA has approved aceclidine ophthalmic solution 1.44%, the first and only FDA-approved aceclidine-based eye drop for the treatment of presbyopia in adults. It is a preservative-free solution. Clinical evidence In a clinical trial involving 466 patients aged 45 to 75 years, aceclidine met all primary and secondary endpoints, improving near vision within 30 minutes and lasting up to 10 hours.
Dosage and administration Available in ophthalmic solution: aceclidine 1.44% in a single-dose vial Dosage: Instill one drop in each eye, wait 2 minutes, and instill a second drop in each eye once daily Contraindications – None Warnings and precautions Blurred vision Risk of retinal tear/detachment Iritis Adverse reactions Instillation site irritation, dim vision, and headache Did you find this FDA Alert interesting? Source : FDA ##Disclaimer## The content provided on Docplexus is intended…
